Author(s):
Prashant D Jadhav, Amol R. Pawar, Vikas V. Patil, Pankaj S. Patil
Email(s):
Email ID Not Available
DOI:
10.52711/0974-4150.2025.00039 
Address:
Prashant D Jadhav1*, Amol R. Pawar1,2*, Vikas V. Patil1, Pankaj S. Patil1
1Department of Quality Assurance, Kisan Vidya Prasarak Sanstha’s, Institute of Pharmaceutical Education, Boradi 425428.
2Research Scholar, Sankalchand Patel University, Visnagar – 384315, Gujarat, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 4,
Year - 2025
ABSTRACT:
Every product in the pharmaceutical sector has some level of risk. The new guidelines define risk as the sum of the potential the damage will occur and the seriousness of that damage. In order to maximize benefits and balance risk, quality risk management, or QRM, is the comprehensive and ongoing process of reducing risks to product quality throughout its lifecycle. It's the methodical method for assessing, managing, discussing, and reviewing threats to the medication's quality. The pharmaceutical business and regulators can assess, discuss, manage, and analyze risk with the use of QRM technologies. There are numerous preferred approaches for risk management in the pharmaceutical sector, including FMEA, FMECA, FTA, HACCP, HAZOP, PHA, Together, risk rating, filtering, and statistical tool analysis offer high dependability, improved quality, enhanced safety, and cost savings that result in shorter development times, less waste, and fewer non-value-added procedures.5
Cite this article:
Prashant D Jadhav, Amol R. Pawar, Vikas V. Patil, Pankaj S. Patil. Recent Advances in Pharmaceutical Quality Risk Management Strategies and Tools. Asian Journal of Research in Chemistry.2025; 18(4):251-4. doi: 10.52711/0974-4150.2025.00039
Cite(Electronic):
Prashant D Jadhav, Amol R. Pawar, Vikas V. Patil, Pankaj S. Patil. Recent Advances in Pharmaceutical Quality Risk Management Strategies and Tools. Asian Journal of Research in Chemistry.2025; 18(4):251-4. doi: 10.52711/0974-4150.2025.00039 Available on: https://ajrconline.org/AbstractView.aspx?PID=2025-18-4-8
REFERENCES:
1. Jain Sanjay Kumar. Quality Risk Management–Application review in pharmaceutical and Biopharamceutical industries by Lorely MILCA Caceres. Bioprocessing Journal. 2010: 26-37
2. Sravya Sivadasu, Gangadharappa H.V, Kiran H.C, Annjewel Jose. Guidance for industry Q9 Quality Risk Management by US department of Health and Human Services, Food and drug Administration. Center for Drug and Evaluation Research. 2006.
3. Sravya Sivadasu, Gangadharappa H.V, Kiran H.C, Annjewel Jose. WHO Guideline on Quality Risk Management A draft guidance. 2010.
4. Imran Bakshi, Kartika Puri, Sukhbir Kaur. International Conference on Harmonization Guidance for Industry: Q9 Quality Risk Management. ICH; 2006
5. Ana Sim˜oes, Francisco Veiga, Carla Vitorino Question-based review for pharmaceutical development: An enhanced quality approach. European Journal of Pharmaceutics and Biopharmaceutics.
6. Nirmal Kumar, Ajeya Jha. Quality risk management during pharmaceutical ‘good distribution practices’–A plausible solution, Bulletin of Faculty of Pharmacy, Cairo University.
7. Sanjay Kumar Jain, Jitendra Kumar Jain, Jagdish Gohel and BhavikSanghavi. Quality risk assessment of equipment with PLC/HMI/SCADA in pharmaceutical industry. The Pharma Innovation Journal. 2022; 11(4): 616-622
8. Abhishek Maithani, Kumar Gaurav. Quality Risk Management (Q9): An Overview. International Journal of Pharmaceutical and Medicinal Research Int. J. Pharm. Med. Res. 2014; 2:68-71
9. Sumukha Krishna P, Gangadharappa HV, Nagendra S, Hemanth Kumar S. An Overview of Risk Management and Risk-based Cleaning Validation. International Journal of Research in Pharmaceutical Sciences. 2020;11(4):5407-5414
10. Aachchhadita Sharma, Raju Mari Jeyaprakash, Rinchi Bora, Abinash Chandra. Review article: Impact of Quality Risk Management Process in Pharmaceutical Industry to Curtail the Non-Conformity.
11. T. A. Mandhare, P.R. Khuspe, P. S. Nangare, R. D. Vyavhare Quality Risk Management: A Review American Journal of Pharm Tech Research. 2018; 8(2).
12. Aachchhadita Sharma, Raju Mari Jeyaprakash, Rinchi Bora, Abinash Chandra. Critical Review of Risk Assessment Tools in Pharmaceutical Quality by Design. Indian Journal of Pharmaceutical Education and Research, 2024; 58(4).
13. Madhavi E. Kadam, Dhwani Bhavsar. A Review of Total Quality Management In Pharmaceutical Industries. International Journal of Creative Research Thoughts (IJCRT). 2022; 10(3).
14. Amrita Das, Praveen Kadwey, Jai Kumar Mishra, Sudheer Moorkoth. Quality Risk Management (QRM) in Pharmaceutical Industry: Tools and Methodology, International Journal of Pharmaceutical Quality Assurance. 2014; 5(3); 13-21.
15. Zanje Abhijit L., Jadhav Vaibhav A. A Review of Total Quality Management in Pharmaceuticals. International Journal of Research Publication and Reviews. 2022; 3(6): 2401-2409
16. Shridhar Betkar, Trupti Nikwade. Review on Quality Assurance and Risk Management in Pharmaceuticals. International Journal of Research Publication and Reviews. 2023; 4(5); 5659-5666.
17. Lotlikar MV. Quality Risk Management (QRM): A Review, Journal of Drug Delivery & Therapeutics. 2013; 3(2): 149-154
18. V. Aswini and K. Kathiresan. Quality Risk Management (QRM): A Review. International Journal of Biology, Pharmacy and Allied Pharmacy. 2022; 11(10): 4667-4678
19. Thomas A. Little, Quality Risk Management for Drug Products and Drug Substances, BioProcess International. 2014; 12(5).
20. Bhawna Sharma. Role of Effective Quality Risk Management in Drug Safety Project, Harrisburg University of Science and Technology Digital Commons at Harrisburg University.
21. Omar A. Ismael, Moyassar I. Ahmed. Using Quality Risk Management in Pharmaceutical Industries: A Case Study. 2020.
22. V Vijayakumar Reddy, N Vishal Gupta, H V Raghunandan, U Nitin Kashyap. Quality Risk Management in Pharmaceutical Industry: A Review. /International. Journal. Pharm Tech Res. 2014; 6(3): 908-914.
23. Ranjana Suryawanshi, Aparark Mohalkar, Radhabai Jadhav, Manjusha Bhange, Ashwini Jankar. Implementation of Quality Risk Management (QRM) In Pharmaceutical Industry: A Review. World Journal of Pharmaceutical Research. 2015; 4(11).
24. Guidance for industry “Q9 Quality Risk Management” by US department of Health and Human Services, Food and drug Administration, Center for Drug and Evaluation Research, June 2006.
25. WHO Guideline on Quality Risk Management A draft guidance August 2010.
26. 3.Implementation of ICH Q9 in the Pharmaceutical Field an Example of Methodology from PIC/S 2010
27. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Q9 Quality Risk Management. Geneva: ICH; 2005.
28. International Conference on Harmonization Guidance for industry: Q9 Quality Risk Management. ICH; 2006.
29. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Q9 Quality Risk Management. Geneva: ICH; 2005.
30. Vjayakumar R, Vishal G, Raghunandan V, Nitin KU. Quality risk Management in Pharmaceutical Industry: A Review. Int J Pharm Tech Res. 2014; 6: 908-14.
31. ISO; 2000. Application of Risk Management to Medical Devices, ISO 14971; 2000. Available from: http://www.iso.org. [Last accessed on 2018 Dec].
32. Das, A. Quality Risk Management (QRM) in Pharmaceutical Industry: Tools and Methodology. International Journal of Pharmaceutical Quality Assurance. 2014; 5: 13–21.
33. Edward 2005. Risk-Based Cleaning Validation in Biopharmaceutical API Manufacturing. Biopharminternational.com.
34. FDA. Guidance for industry-quality systems approach to pharmaceutical cGMP regulations. Risk Manag. 2006:1-28.
35. Wallace CA, Holyoak L, Powell SC, Dykes FC, HACCP. The difficulty with Hazard Analysis. Food Control. 2014; 35(1): 233-40.
36. WHO. Application of Hazard Analysis and Critical Control Point (HACCP) methodology to pharmaceuticals. World Health Organ Tech Rep S. 2003; 908: 99-112.
37. FDA. Guidance for industry-quality systems approach to pharmaceutical cGMP regulations. Risk Manag. 2006:1-28
38. European Medicines Agency (EMA). ICH Guideline Q9 on quality Risk Management. 2014; 44(1):1-20.
39. Risk Assessment Guidance. Health and safety services. University of Leeds:1-37 Quality and Risk Management Standard. Feidhmeannachtnaseirbhi Slainte. Health Service Executive. 2007: 1-23.